4//SEC Filing
NANOVIRICIDES, INC. 4
Accession 0001140361-14-035027
$NNVCCIK 0001379006operating
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 6:22 PM ET
Size
7.5 KB
Accession
0001140361-14-035027
Insider Transaction Report
Form 4
Diwan Anil
DirectorPresident10% Owner
Transactions
- Purchase
Common Stock, par value $0.001 per share
2014-08-25$3.50/sh+28,571$99,999→ 2,044,918 total(indirect: Held by AllExcel, Inc.) - Exercise of In-Money
Common Stock Warrants
2014-08-25−28,571→ 0 total(indirect: Held by AllExcel, Inc.)Exercise: $3.50From: 2008-08-22Exp: 2014-08-15→ Common Stock (28,571 underlying)
Footnotes (1)
- [F1]Includes 285,714 shares issuable upon exercise of options. Does not include 1,750,000 shares of common stock underlying 500,000 shares of the Company's Series A Convertible Preferred Stock ("Series A") convertible into three and one half shares of Common Stock solely upon a change in control of the Company or upon achieving certain trading prices or 9,531,429 shares of common stock and 2,000,000 shares of Series A owned by TheraCour Pharma, Inc., over which Dr. Diwan holds voting and dispositive power.
Documents
Issuer
NANOVIRICIDES, INC.
CIK 0001379006
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001379006
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 6:22 PM ET
- Size
- 7.5 KB